{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:09:53Z","timestamp":1773839393426,"version":"3.50.1"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T00:00:00Z","timestamp":1673827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>With the discovery of novel diseases and pathways, as well as a new outlook on certain existing diseases, cellular trafficking disorders attract a great deal of interest and focus. Understanding the function of genes and their products in protein and lipid synthesis, cargo sorting, packaging, and delivery has allowed us to appreciate the intricate pathophysiology of these biological processes at the molecular level and the multi-system disease manifestations of these disorders. This article focuses primarily on lymphocyte intracellular trafficking diseases from a clinician\u2019s perspective. Familial hemophagocytic lymphohistiocytosis is the prototypical disease of abnormal vesicular transport in the lymphocytes. In this review, we highlight other mechanisms involved in cellular trafficking, including membrane contact sites, autophagy, and abnormalities of cytoskeletal structures affecting the immune cell function, based on a newer classification system, along with management aspects of these conditions.<\/jats:p>","DOI":"10.3389\/fimmu.2022.1034317","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:01:30Z","timestamp":1673845290000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Traffic jam within lymphocytes: A clinician\u2019s perspective"],"prefix":"10.3389","volume":"13","author":[{"given":"Smitha","family":"Hosahalli Vasanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jignesh","family":"Dalal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/TRA.12615","article-title":"TRAPPopathies: An emerging set of disorders linked to variations in the genes encoding transport protein particle (TRAPP)-associated proteins","volume":"20","author":"Sacher","year":"2019","journal-title":"Traffic"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020408","article-title":"ER-to-Golgi trafficking and its implication in neurological diseases","volume":"9","author":"Wang","year":"2020","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1620\/tjem.242.63","article-title":"Membrane trafficking illuminates a path to parkinson\u2019s disease","volume":"242","author":"Hasegawa","year":"2017","journal-title":"Tohoku J Exp Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq100","article-title":"Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations","volume":"19","author":"Urwin","year":"2010","journal-title":"Hum Mol Genet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2946","article-title":"Hereditary spastic paraplegias: membrane traffic and the motor pathway HHS public access","volume":"12","author":"Blackstone","year":"2017","journal-title":"Nat Rev Neurosci"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00400","article-title":"Golgi fragmentation in amyotrophic lateral sclerosis, an overview of possible triggers and consequences","volume":"9","author":"Haase","year":"2015","journal-title":"Front Neurosci"},{"key":"B7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/J.PNEUROBIO.2012.03.003","article-title":"Charcot\u2013Marie\u2013Tooth disease and intracellular traffic","volume":"99","author":"Bucci","year":"2012","journal-title":"Prog Neurobiol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/J.TIG.2022.02.012","article-title":"Genetic disorders of cellular trafficking","volume":"38","author":"Garc\u00eda-Cazorla","year":"2022","journal-title":"Trends Genet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1242\/DMM.043448","article-title":"Membrane trafficking in health and disease","volume":"13","author":"Yarwood","year":"2020","journal-title":"Dis Model Mech"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7696(06)52005-4","article-title":"Cell biology of membrane trafficking in human disease","volume":"252","author":"Howell","year":"2006","journal-title":"Int Rev Cytol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/S12964-021-00730-1","article-title":"The exosome journey: from biogenesis to uptake and intracellular signalling","volume":"19","author":"Gurung","year":"2021","journal-title":"Cell Commun Signal"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)01079-1","article-title":"The mechanisms of vesicle budding and fusion","volume":"116","author":"Bonifacino","year":"2004","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS21072576","article-title":"Lysosomal exocytosis, exosome release and secretory autophagy: The autophagic- and endo-lysosomal systems go extracellular","volume":"21","author":"Buratta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0092-8674(00)81687-6","article-title":"The road taken: Past and future foundations of membrane traffic | request PDF","volume":"100","author":"Mellman","year":"2000","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1182\/ASHEDUCATION-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka","year":"2013","journal-title":"Hematology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/S00431-006-0258-1","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"166","author":"Janka","year":"2007","journal-title":"Eur J Pediatr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/ACI.0B013E32834C22F5","article-title":"The expanding spectrum of hemophagocytic lymphohistiocytosis","volume":"11","author":"Filipovich","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1086\/302187","article-title":"Localization of a gene for familial hemophagocytic lymphohistiocytosis at chromosome 9q21.3-22 by homozygosity mapping","volume":"64","author":"Ohadi","year":"1999","journal-title":"Am J Hum Genet"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.1034\/j.1600-0749.2002.02038.x","article-title":"Chediak-Higashi Syndrome: a rare disorder of lysosomes and lysosome related organelles","volume-title":"Pigment Cell Res","author":"Shiflett","year":"2002"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ddmod.2019.10.008","article-title":"Chediak-higashi syndrome: A review of the past, present, and future","volume":"31","author":"Sharma","year":"2020","journal-title":"Drug Discovery Today Dis Models"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.5582\/irdr.2016.01084","article-title":"Griscelli syndrome subtype 2 with hemophagocytic lympho-histiocytosis: A case report and review of literature","volume":"6","author":"Minocha","year":"2017","journal-title":"Intractable Rare Dis Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-11-4413","article-title":"Lethal hemophagocytic lymphohistiocytosis in hermansky-pudlak syndrome type II","volume":"108","author":"Enders","year":"2006","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jaip.2019.04.001","article-title":"Hermansky-pudlak syndrome type II and lethal hemophagocytic lymphohistiocytosis: Case description and review of the literature","volume":"7","author":"Dell\u2019Acqua","year":"2019","journal-title":"J Allergy Clin Immunol: In Practice"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-10","article-title":"The risk of hemophagocytic lymphohistiocytosis in hermansky-pudlak syndrome type 2","volume":"121","author":"Jessen","year":"2013","journal-title":"Blood"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000001522","article-title":"Griscelli type 2 syndrome and hemophagocytic lymphohistiocytosis: Sisters with the same mutation but different presentations","volume":"41","author":"Russ","year":"2019","journal-title":"J Pediatr Hematol Oncol"},{"key":"B26","volume-title":"Analysis of the lysosomal storage disease chediak-higashi syndrome clinical symptoms","author":"Mcvey Ward","year":"2000"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-021-02720-1","article-title":"Successful rescue of a lethal griscelli syndrome type 2 presenting with neurological involvement and hemophagocytic lymphohistiocytosis: a case report","volume":"21","author":"Zhang","year":"2021","journal-title":"BMC Pediatr"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2013-11-538686","article-title":"XMEN disease: A new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus","volume":"123","author":"Li","year":"2014","journal-title":"Blood"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2018.00666","article-title":"Schwartzberg PL. X-linked lymphoproliferative disease type 1: A clinical and molecular perspective","volume":"9","author":"Panchal","year":"2018","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-014-0083-7","article-title":"XLP: Clinical features and molecular etiology due to mutations in SH2D1A encoding SAP","volume":"34","author":"Tangye","year":"2014","journal-title":"J Clin Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-016-0271-8","article-title":"Copa syndrome: a novel autosomal dominant immune dysregulatory disease","volume":"36","author":"Vece","year":"2016","journal-title":"J Clin Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/JMEDGENET-2018-105560","article-title":"Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features","volume":"56","author":"Taveira-Dasilva","year":"2019","journal-title":"J Med Genet"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.20200600","article-title":"Mutations in COPA lead to abnormal trafficking of STING to the golgi and interferon signaling","volume":"217","author":"Lepelley","year":"2020","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.773112","article-title":"Miao h. a novel mutation c.841C>T in COPA syndrome of an 11-Year-Old boy: A case report and short literature review","volume":"9","author":"Zeng","year":"2021","journal-title":"Front Pediatr"},{"key":"B35","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/BF03402003\/FIGURES\/2","article-title":"The chediak-higashi protein interacts with SNARE complex and signal transduction proteins","volume":"8","author":"Tchernev","year":"2002","journal-title":"Mol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.178.6.1845","article-title":"The giant organelles in beige and chediak-higashi fibroblasts are derived from late endosomes and mature lysosomes","volume":"178","author":"Burkhardt","year":"1993","journal-title":"J Exp Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/TRA.12227","article-title":"LYST affects lysosome size and quantity, but not trafficking or degradation through autophagy or endocytosis","volume":"15","author":"Holland","year":"2014","journal-title":"Traffic"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/J.1600-0854.2011.01300.X","article-title":"The enlarged lysosomes in beige j cells result from decreased lysosome fission and not increased lysosome fusion","volume":"13","author":"Durchfort","year":"2012","journal-title":"Traffic"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/J.JACI.2015.08.039","article-title":"Chediak-higashi syndrome: LYST domains regulate exocytosis of lytic granules, but not cytokine secretion by NK cells","volume":"137","author":"Gil-Krzewska","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"16795","DOI":"10.1073\/PNAS.0405905101","article-title":"From the cover: Defective lysosomal exocytosis and plasma membrane repair in chediak\u2013higashi\/beige cells","volume":"101","author":"Huynh","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.2174\/1566524023362357","article-title":"Disorders of vesicles of lysosomal lineage: The hermansky- pudlak syndromes","volume":"2","author":"Huizing","year":"2005","journal-title":"Curr Mol Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1083\/JCB.200311064","article-title":"Localization of the AP-3 adaptor complex defines a novel endosomal exit site for lysosomal membrane proteins","volume":"164","author":"Peden","year":"2004","journal-title":"J Cell Biol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.10.026","article-title":"Autophagy: renovation of cells and tissues","volume":"147","author":"Mizushima","year":"2011","journal-title":"Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cr.2013.161","article-title":"Autophagy and human diseases","volume":"24","author":"Jiang","year":"2014","journal-title":"Cell Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1093\/BRAIN\/AWV393","article-title":"EPG5-related vici syndrome: A paradigm of neurodevelopmental disorders with defective autophagy","volume":"139","author":"Byrne","year":"2016","journal-title":"Brain"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/NG.2497","article-title":"Recessive mutations in EPG5 cause vici syndrome, a multisystem disorder with defective autophagy","volume":"45","author":"Cullup","year":"2013","journal-title":"Nat Genet"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022302","article-title":"Vici syndrome with pathogenic homozygous EPG5 gene mutation: A case report and literature review","volume":"99","author":"Abidi","year":"2020","journal-title":"Medicine"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13023-016-0399-X\/TABLES\/3","article-title":"Vici syndrome: A review","volume":"11","author":"Byrne","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"B49","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1158\/1078-0432.CCR-10-2634","article-title":"Principles and current strategies for targeting autophagy for cancer treatment","volume":"17","author":"Amaravadi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.206433","article-title":"Actin assembly mechanisms at a glance","author":"Rottner","year":"2017"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/J.DEVCEL.2009.09.010","article-title":"The Arp2\/3 activator WASH controls the fission of endosomes through a large multiprotein complex","volume":"17","author":"Derivery","year":"2009","journal-title":"Dev Cell"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913293107","article-title":"WASH and WAVE actin regulators of the wiskott-Aldrich syndrome protein (WASP) family are controlled by analogous structurally related complexes","volume":"107","author":"Jia","year":"2010","journal-title":"Proc Natl Acad Sci U A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/J.TCB.2008.06.007","article-title":"The ghost in the machine: small GTPases as spatial regulators of exocytosis","volume":"18","author":"Wu","year":"2008","journal-title":"Trends Cell Biol"},{"key":"B54","first-page":"26","volume-title":"NRA Of the NY, 2013 undefined. Wiskott\u2010Aldrich syndrome: a comprehensive review","author":"Massaad","year":"2013"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)82002-5","article-title":"A multiinstitutional survey of the wiskott-Aldrich syndrome","volume":"125","author":"Sullivan","year":"1994","journal-title":"J Pediatr"},{"key":"B56","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/TACG.S58444","article-title":"Wiskott-Aldrich syndrome: Diagnosis, current management, and emerging treatments","volume":"7","author":"Buchbinder","year":"2014","journal-title":"Appl Clin Genet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/J.AJHG.2017.12.015","article-title":"Functional dysregulation of CDC42 causes diverse developmental phenotypes","volume":"102","author":"Martinelli","year":"2018","journal-title":"Am J Hum Genet"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1002\/AJMG.A.37526","article-title":"Further evidence of a mutation in CDC42 as a cause of a recognizable syndromic form of thrombocytopenia","volume":"170","author":"Takenouchi","year":"2016","journal-title":"Am J Med Genet A"},{"key":"B59","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/genes12020294","article-title":"Pancytopenia, recurrent infection, poor wound healing, heterotopia of the brain probably associated with a candidate novel de Novo CDC42 gene defect: Expanding the molecular and phenotypic spectrum","volume":"12","author":"Asiri","year":"2021","journal-title":"Genes (Basel)"},{"key":"B60","first-page":"31","author":"Lam","year":"2019"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00318","article-title":"A novel CDC42 mutation in an 11-year old child manifesting as syndromic immunodeficiency, autoinflammation, hemophagocytic lymphohistiocytosis, and malignancy: A case report","volume":"11","author":"Szczawinska-Poplonyk","year":"2020","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/J.JACI.2019.06.017","article-title":"Severe autoinflammation in 4 patients with c-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1\u03b2 inhibition","volume":"144","author":"Gernez","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrm729","article-title":"The vacuolar (H+)-ATPases \u2014 nature\u2019s most versatile proton pumps","volume":"3","author":"Nishi","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006195","article-title":"Expanding the phenotype of ATP6AP1 deficiency","volume":"8","author":"Barua","year":"2022","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1111\/PETR.13808","article-title":"Liver failure and x-linked immunodeficiency type 47","volume":"24","author":"Gumm","year":"2020","journal-title":"Pediatr Transplant"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1590\/S1807-59322006000400009","article-title":"Polarized light microscopy of hair shafts aids in the differential diagnosis of ch\u00e9diak-higashi and griscelli-prunieras syndromes","volume":"61","author":"Valente","year":"2006","journal-title":"Clinics (Sao Paulo)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/ijt.ijt_21_16","article-title":"Light microscopy and polarized microscopy: A dermatological tool to diagnose Gray hair syndromes","volume":"9","author":"Chandravathi","year":"2017","journal-title":"Int J Trichol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2016-12-753830","article-title":"Perforin and CD107a testing is superior to NK cell function testing for screening patients for genetic HLH","volume":"129","author":"Rubin","year":"2017","journal-title":"Blood"},{"key":"B69","doi-asserted-by":"crossref","unstructured":"CarvelliJ\n            PiperoglouC\n            FarnarierC\n          Functional and genetic testing in adults with HLH reveals an inflammatory profile rather than a cytotoxicity defect2020","DOI":"10.1182\/blood.2019003664"},{"key":"B70","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1182\/BLOOD-2017-11-814244","article-title":"Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis","volume":"132","author":"Chinn","year":"2018","journal-title":"Blood"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/S10875-017-0443-1","article-title":"Effective immunological guidance of genetic analyses including exome sequencing in patients evaluated for hemophagocytic lymphohistiocytosis","volume":"37","author":"Ammann","year":"2017","journal-title":"J Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41390-022-02263-w","article-title":"Multisystem inflammatory syndrome in children (MIS-c) and neonates (MIS-n) associated with COVID-19: optimizing definition and management","volume":"1","author":"Molloy","year":"2022","journal-title":"Pediatr Res"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Sci (1979)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3899\/JRHEUM.200292","article-title":"Predicting macrophage activation syndrome in childhood-onset systemic lupus erythematosus patients at diagnosis","volume":"48","author":"Gerstein","year":"2021","journal-title":"J Rheumatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/art.38690","article-title":"Development and validation of the hscore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"130","author":"Bergsten","year":"2017","journal-title":"Blood"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/PCC.0000000000000078","article-title":"Therapeutic role of anakinra, an interleukin-1 receptor antagonist, in the management of secondary hemophagocytic lymphohistiocytosis\/sepsis\/multiple organ dysfunction\/macrophage activating syndrome in critically ill children","volume":"15","author":"Rajasekaran","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1002\/art.41103","article-title":"Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis","volume":"72","author":"Eloseily","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/PBC.28581","article-title":"The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis","volume":"67","author":"Bami","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.28813","article-title":"Comment on: The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis","volume":"68","author":"Vicenzi","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1200\/JCO.2002.20.2.599","article-title":"Intravenous immunoglobulin for hemophagocytic lymphohistiocytosis","volume":"20","author":"Emmenegger","year":"2016","journal-title":"J Clin Oncol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i21.3394","article-title":"Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and \u03b3- immunoglobulin infusions","volume":"7","author":"Georgiadou","year":"2019","journal-title":"World J Clin Cases"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1182\/BLOODADVANCES.2020002101","article-title":"Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study","volume":"4","author":"Bergsten","year":"2020","journal-title":"Blood Adv"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1358\/DOT.2020.56.7.3145359","article-title":"Emapalumab for the treatment of hemophagocytic lymphohistiocytosis","volume":"56","author":"Cheloff","year":"2020","journal-title":"Drugs Today (Barc)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s40265-018-1046-8","article-title":"Emapalumab: First global approval","volume":"79","author":"Al-Salama","year":"2019","journal-title":"Drugs"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608492","article-title":"Novel therapeutic approaches to familial HLH (Emapalumab in FHL)","volume":"11","author":"Merli","year":"2020","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Wiley Online Library"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1182\/BLOODADVANCES.2017007526","article-title":"Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis","volume":"1","author":"Broglie","year":"2017","journal-title":"Blood Adv"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2019.222471","article-title":"Ruxolitinib for refractory\/relapsed hemophagocytic lymphohistiocytosis","volume":"105","author":"Wang","year":"2020","journal-title":"Haematologica"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13593","article-title":"Ruxolitinib as adjunctive therapy for secondary hemophagocytic lymphohistiocytosis: A case series","volume":"106","author":"Hansen","year":"2021","journal-title":"Eur J Haematol"},{"key":"B91","doi-asserted-by":"crossref","unstructured":"LiuP\n            PanX\n            ChenC\n          Nivolumab treatment of relapsed\/refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults2020","DOI":"10.1182\/blood.2019003886"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.2020005041","article-title":"Checkmate for EBV-HLH","volume":"135","author":"El-Mallawany","year":"2020","journal-title":"Blood"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.2174\/1566523214666140918112113","article-title":"Gene therapy for haemophagocytic lymphohistiocytosis","volume":"14","author":"Booth","year":"2014","journal-title":"Curr Gene Ther"},{"key":"B94","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/J.JACI.2017.11.050","article-title":"T-Cell gene therapy for perforin deficiency corrects\u00a0cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations","volume":"142","author":"Ghosh","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.V122.21.4214.4214","article-title":"Stem cell and T-cell gene therapy using SIN-lentiviral vector in type 3 familial hemophagocytic lymphohistiocytosis","volume":"122","author":"Rivi\u00e8re","year":"2013","journal-title":"Blood"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1089\/HUM.2019.329","article-title":"Lentiviral gene therapy for familial hemophagocytic lymphohistiocytosis type 3, caused by UNC13D genetic defects","volume":"31","author":"Takushi","year":"2020","journal-title":"Hum Gene Ther"},{"key":"B97","doi-asserted-by":"publisher","first-page":"78","DOI":"10.5152\/EURJRHEUM.2019.18177","article-title":"Baricitinib in therapy of COPA syndrome in a 15-year-old girl","volume":"7","author":"Krutzke","year":"2019","journal-title":"undefined"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3624795","article-title":"Lung transplantation in a patient with COPA syndrome","volume":"2020","author":"Mallea","year":"2020","journal-title":"Case Rep Transplant"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/J.EKIR.2019.04.014","article-title":"COPA syndrome as a cause of lupus nephritis","volume":"4","author":"Boulisfane-El Khalifi","year":"2019","journal-title":"Kidney Int Rep"},{"key":"B100","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/14397595.2019.1583832","article-title":"Safety and tolerability of sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study","volume":"30","author":"Takeuchi","year":"2020","journal-title":"Mod Rheumatol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00017-2018","article-title":"Analysis of pulmonary features and treatment approaches in the COPA syndrome","volume":"4","author":"Tsui","year":"2018","journal-title":"Eur Respir Soc"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019002939","article-title":"Excellent outcomes following hematopoietic cell transplantation for wiskott-Aldrich syndrome: A PIDTC report","volume":"135","author":"Burroughs","year":"2020","journal-title":"Blood"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1062366","article-title":"Current and emerging treatment options for wiskott-Aldrich syndrome","volume":"11","author":"Worth","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1016\/J.IAC.2010.02.001","article-title":"Hematopoietic cell transplantation for wiskott-Aldrich syndrome: advances in biology and future directions for treatment","volume":"30","author":"Pai","year":"2010","journal-title":"Immunol Allergy Clin North Am"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1034317\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T05:01:34Z","timestamp":1673845294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1034317\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":104,"alternative-id":["10.3389\/fimmu.2022.1034317"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1034317","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,16]]},"article-number":"1034317"}}